Загрузка...
Cardiotoxicity from immune checkpoint inhibitors
Immune checkpoint inhibitor (ICI) therapy has greatly improved treatment of various advanced cancers but increasing use of ICI therapy has exposed the risk of ICI-related cardiovascular side effects. Immune checkpoints are inhibitory regulators of T cell activation and mediate T cell effector functi...
Сохранить в:
| Опубликовано в: : | Int J Cardiol Heart Vasc |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736791/ https://ncbi.nlm.nih.gov/pubmed/31517036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2019.100420 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|